Get my own profile
Public access
View all30 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Caroline HeckmanUniversity of Helsinki, Institute for Molecular Medicine Finland FIMM-HiLIFEVerified email at helsinki.fi
- Kimmo PorkkaProfessor of hematology, Helsinki University Hospital Cancer CenterVerified email at helsinki.fi
- Olli KallioniemiDirector, Science for Life Laboratory and the data-driven life science programVerified email at scilifelab.se
- Satu MustjokiUniversity of HelsinkiVerified email at helsinki.fi
- Sonja LagströmScientistVerified email at agilent.com
- Mika KontroHelsinki University Hospital and Institute for Molecular Medicine FinlandVerified email at helsinki.fi
- Krister WennerbergBRIC, University of CopenhagenVerified email at fimm.fi
- Muntasir Mamun MajumderAstraZeneca R&DVerified email at astrazeneca.com
- Heikki KuusanmäkiInstitute for Molecular Medicine Finland (FIMM), University of HelsinkiVerified email at helsinki.fi
- Dr. Bhagwan Yadav, PhDUniversity of HelsinkiVerified email at helsinki.fi
- jarek maciejewskiVerified email at ccf.org
- Tea Pemovska, PhDSenior Postdoctoral Researcher at Medical University of ViennaVerified email at meduniwien.ac.at
- Thomas OlsonVirginia Commonwealth University HealthVerified email at vcuhealth.org
- Bjorn T. GjertsenProfessor of Hematology, University of BergenVerified email at uib.no
- Ashwini KumarSenior Scientist Johnson & Johnson R&DVerified email at helsinki.fi
- Tero AittokallioUniversity of Helsinki, University of Turku, University of OsloVerified email at utu.fi
- Disha MalaniInstitute for Molecular Medicine Finland (FIMM), University of HelsinkiVerified email at helsinki.fi
- Tiina KelkkaVerified email at helsinki.fi
- Sabrina BortoluzziTechnical University MunichVerified email at tum.de
- Riikka KarjalainenVerified email at helsinki.fi
Follow
Samuli Eldfors, PhD
Research Fellow, MGH, Harvard Medical School
Verified email at mgh.harvard.edu